The NCCN 2023 Annual Congress: Hematologic Malignancies™ was held on September 22-23, 2023 in San Francisco and virtually.
Save the dates! The NCCN 2024 Annual Congress: Hematologic Malignancies™ will take place Friday, September 20, 2024 – Saturday, September 21, 2024, at the New York Marriott Marquis in New York, New York.
Congress attendees will have the opportunity to view sessions on-demand in the Virtual Event Platform through December 2023. Recorded sessions will be available in the NCCN Continuing Education Portal, education.nccn.org, later this year.
Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, this program featured presentations and interactive discussions highlighting the treatment options and supportive care for a variety of hematologic malignancies. This program was approved for AMA PRA Category 1 Credit™ and ABIM, ABPath, and ABMS MOC for physicians and was also certified for credit for nurses, pharmacists, and other oncology professionals.
Disease areas covered:
For CE program supporter opportunities, contact Lisa Perfidio, Senior Manager, CE Supporter Outreach.
This activity is supported through educational grants from:
This educational activity is supported by a medical education grant from:
This educational activity is supported by independent educational grants from:
This activity is supported by an unrestricted educational grant provided by:
Supported by a grant from:
Supported by an educational grant from:
Important Alert About Fraudulent Sites
Information about this Congress may appear on fraudulent websites that appear to offer registration, exhibit space, and hotel rooms at discounted rates. These companies are in no way affiliated with NCCN or the Hilton San Francisco Union Square. Please do not book any registrations or reservations through these sites, and register only through NCCN. If you have any questions or concerns, contact email@example.com.